jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Jan. 23, 2022

Jan. 23, 2022

jRCT1071210120

An ancillary study of 'Investigation of efficacy of nivolumab in patients with recurrent and refractory peripheral T cell lymphoma: Investigator initiated phase 2 clinical trial' (W-JHS NHL02-A)

W-JHS NHL02-A study (W-JHS NHL02-A)

Akashi Koichi

Kyushu University Graduate School of Medical Science

3-1-1 Maidashi, Higashi-ku, Fukuoka-city, Fukuoka 812-8582, Japan

+81-92-642-5230

akashi@med.kyushu-u.ac.jp

Koji Kato

Kyushu University Hospital

3-1-1 Maidashi, Higashi-ku, Fukuoka-city, Fukuoka 812-8582, Japan

+81-92-642-5230

kato.koji.429@m.kyushu-u.ac.jp

Not Recruiting

July. 01, 2018

April. 25, 2019
20

Observational

1) Patients enrolled in W-JHS NHL02 study (jRCT2071210101)
2) Patients providing the written informed consent.
3) Patients whose specimens for any test in 'biomarker exploration' can be submitted

Nothing particular

20age old over
No limit

Both

Peripheral T-cell lymphoma (including extranodal NK/T-cell lymphoma)

Gene and protein expression, gene mutation, lymphocyte subset analysis, serum cytokine and chemokine, HLA gene, single cell analysis

Nothing

Kyushu University Hospital
Ono Pharmaceutical Co., Ltd.
Not applicable
NPO Clinical Research Network Fukuoka Ethics Committee
3-1-1 Maidashi, Higashi-ku, Fukuoka-city, Fukuoka 812-8582, Japan, Fukuoka

+81-92-643-7171

mail@crnfukuoka.jp
Approval

Sept. 20, 2018

No

UMIN000034502
University hospital Medical Information Network (UMIN)

none